ALK-Abelló is a research based pharmaceutical company and a world leader in allergen specific immunotherapy since 1923. ALK-Abelló’s place in the UK market for specific allergy treatment is founded on continuous growth and development.
Our market leading position is based on investing in a network of mutually profitable partnerships, to diagnose and treat allergic diseases.